6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

244-NETWORK CONTRACT OFFICE 4 (36C244)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24426Q0900

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its Network Contracting Office 4 (NCO 4), has awarded a firm-fixed price contract for the supply of Fluorodeoxyglucose (FDG) Radiopharmaceuticals to the Philadelphia VA Medical Center, located at 3900 Woodland Ave, Philadelphia, PA 19104. This procurement is structured with a base year and includes four additional option years, which may be exercised at the Government’s discretion, ensuring continuity of supply and flexibility in contract management. The total estimated value of the award is $637,630.00. The primary objective of this contract is to secure a reliable source of FDG radiopharmaceuticals, which are critical for diagnostic imaging procedures, particularly positron emission tomography (PET) scans. These radiopharmaceuticals play a vital role in the diagnosis and management of various medical conditions, including cancer, by enabling high-precision imaging. The scope of the contract encompasses the manufacturing, quality assurance, and timely delivery of FDG radiopharmaceuticals in accordance with the stringent requirements of the Philadelphia VA Medical Center. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating drugs and biologicals. The contract is managed by the 244-Network Contract Office 4, a federal office within the Department of Veterans Affairs, ensuring adherence to federal acquisition regulations and VA-specific procurement policies. The awarded contract is a firm-fixed price type, providing cost predictability for the VA and ensuring that the contractor delivers the specified radiopharmaceuticals at agreed-upon prices throughout the contract period. There are no set-aside requirements or special considerations indicated in the notice, suggesting that the procurement was open to all qualified vendors capable of meeting the technical and regulatory standards for pharmaceutical manufacturing and supply. For further information or contract-related inquiries, the primary point of contact is Jefferson Mann, who can be reached via email at [email protected] or by phone at 412-860-7204. Additional details and official documentation related to this award can be accessed through the SAM.gov opportunity listing at https://sam.gov/opp/d2a85f075a8d4fe0adebdf418301e138/view. This contract represents a significant commitment by the Department of Veterans Affairs to ensure that the Philadelphia VA Medical Center is equipped with essential radiopharmaceuticals, supporting the delivery of advanced diagnostic services to veterans in the region over the coming years.